- Home
- AMRN vs PEBK Comparison
AMRN vs PEBK Comparison
Compare AMRN & PEBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRN
- PEBK
- Stock Information
- Founded
- AMRN 1989
- PEBK 1912
- Country
- AMRN Ireland
- PEBK United States
- Employees
- AMRN N/A
- PEBK N/A
- Industry
- AMRN Biotechnology: Pharmaceutical Preparations
- PEBK Major Banks
- Sector
- AMRN Health Care
- PEBK Finance
- Exchange
- AMRN Nasdaq
- PEBK Nasdaq
- Market Cap
- AMRN 191.2M
- PEBK 169.6M
- IPO Year
- AMRN 1993
- PEBK N/A
- Fundamental
- Price
- AMRN $0.46
- PEBK $32.65
- Analyst Decision
- AMRN Buy
- PEBK
- Analyst Count
- AMRN 1
- PEBK 0
- Target Price
- AMRN N/A
- PEBK N/A
- AVG Volume (30 Days)
- AMRN 1.6M
- PEBK 29.2K
- Earning Date
- AMRN 10-30-2024
- PEBK 01-21-2025
- Dividend Yield
- AMRN N/A
- PEBK 2.35%
- EPS Growth
- AMRN N/A
- PEBK 1.99
- EPS
- AMRN N/A
- PEBK 2.95
- Revenue
- AMRN $241,021,000.00
- PEBK $79,995,000.00
- Revenue This Year
- AMRN N/A
- PEBK N/A
- Revenue Next Year
- AMRN N/A
- PEBK N/A
- P/E Ratio
- AMRN N/A
- PEBK $11.00
- Revenue Growth
- AMRN N/A
- PEBK 3.47
- 52 Week Low
- AMRN $0.45
- PEBK $23.74
- 52 Week High
- AMRN $1.37
- PEBK $33.31
- Technical
- Relative Strength Index (RSI)
- AMRN 38.11
- PEBK 74.23
- Support Level
- AMRN $0.45
- PEBK $31.64
- Resistance Level
- AMRN $0.50
- PEBK $32.64
- Average True Range (ATR)
- AMRN 0.03
- PEBK 0.68
- MACD
- AMRN -0.00
- PEBK -0.08
- Stochastic Oscillator
- AMRN 12.50
- PEBK 70.54
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About PEBK Peoples Bancorp of North Carolina Inc.
Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh, and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.